Metagenomic and metaproteomic approaches have been used to study the composition 23 and functions of the microbiota. However, no studies have examined post-translational 24 modifications (PTM) on human microbiome proteins at the metaproteome level, and it 25 remains unknown whether the microbial PTM is altered or not in patient microbiome. 26 Herein we used anti-acetyl-lysine (Kac) antibody enrichment strategy and mass 27 spectrometry to characterize the protein lysine acetylation in human microbiome, which 28 successfully identified 35,200 Kac peptides corresponding to 31,821 Kac sites from the 29 microbial or host proteins in human gut microbiome samples. The gut microbial proteins 30 exhibited Kac motifs that were distinct from those of human proteins. Functional analysis 31 showed that microbial Kac proteins were significantly enriched in energy production and 32 abundant in enzymes related to transferases and oxidoreductases. Applying to the 33 analysis of pediatric Crohn's disease (CD) patient microbiome identified 52 host and 136 34 microbial protein Kac sites that were differentially abundant in CD versus controls. 35 Interestingly, most of the decreased Kac sites in CD were derived from Firmicutes and 36 most of the increased sites were derived from Bacteroidetes. Forty-six out of the 52 37 differentially abundant human protein Kac sites were increased in CD patients, including 38 those on calprotectin, lactotransferrin and immunoglobulins. Taken together, this study 39 provides an efficient approach to study the lysine acetylation in microbiome and revealed 40 taxon-specific alterations in the lysine acetylome as well as changes in host protein 41 acetylation levels in intestinal samples during the on-set of disease in CD patients. 42 43 Keywords 44 Crohn's disease, lysine acetylation, mass spectrometry, metaproteomics, microbiome 45 46 Protein name Low High Z-score
Introduction 47
The intestinal microbiome is emerging as an important "organ" within the human body 48 that actively interacts with its host to influence human health [1] . Dysbiosis of the 49 intestinal microbiota has been reported to be associated with a myriad of diseases, 50 including obesity, diabetes, Crohn's disease (CD), cancer, and cardiovascular diseases 51
[2]. In the past few years, meta-omic approaches, including metagenomics, 52 metatranscriptomics and metaproteomics, have been applied to study the alterations of 53 the microbiome composition and functions in patients with these diseases [3] [4] [5] [6] . 54
However, very little is known of the regulatory processes in the microbiome, such as 55 post-translational modifications (PTMs) that are known to regulate the activity of proteins. 56
In fact, there are currently no published studies on the global and deep characterization 57 of PTMs in the human microbiome, nor published techniques for the efficient PTM 58 profiling at the metaproteome level. 59
Acetylation is an important PTM in both Eukaryotes and Prokaryotes [7, 8] . In particular, 60 lysine (N ε ) acetylation has been shown to be involved in the regulation of various 61 biological processes, including transcription and metabolism [8, 9] . Protein lysine 62 acetylation has been characterized in several single bacterial species including 63
Escherichia coli [10] [11] [12] [13] , Bacillus subtilis [14] , Salmonella enterica [8] and 64
Mycobacterium tuberculosis [15] . In bacteria, up to 40% of proteins can be acetylated 65 [16] . Lysine acetylation has been widely implicated in various microbial processes 66 including chemotaxis [17] , nutrient metabolism [13] , stress response [13] and virulence 67
[18]. These findings highlight the importance of studying protein acetylation in the 68 microbiome. However, as mentioned above, no study has yet globally examined protein 69 acetylation in human microbiomes, and very little is known about protein acetylation 70 within the microbiome in the context of diseases such as CD. 71
In this study, we first established experimental and bioinformatic workflows for 72 characterization of the microbiome lysine acetylation. Briefly, an immuno-affinity-based 73 approach was used for the enrichment of acetyl-lysine (Kac) peptides from the 74 microbiome protein digests; the eluted peptides were analyzed with Orbitrap-based 75 mass spectrometer (MS); and the MS data was then processed using an integrative 76 metaproteomics/lysine acetylomics bioinformatic workflow that was developed in the 77 current study. Lysine acetylome profiling of the human gut microbiome was then 78 performed with fecal samples collected from six healthy adults. In total, 35,200 Kac 79 peptides corresponding to 31,821 Kac sites were identified from either human or 80 microbial proteins, which enabled deep characterization of the Kac motif and protein 81 functions in the human microbiome. To the best of our knowledge, this is the first global 82 characterization of Kac proteins in human microbiomes and achieved the highest 83 number of site identification in lysine acetylomic studies. We further applied the 84 approach to study the alterations of lysine acetylation in intestinal aspirate samples 85 In this study, the proteolytic peptides generated from each microbiome sample were 97 divided into two aliquots to allow for both metaproteomics and lysine acetylomics 98 analysis. Lysine acetylated peptides from the first aliquot were enriched using a seven-99 plex anti-Kac peptide antibody cocktail (PTMScan® acetyl-lysine motif [Ac-K] kit) [19] ; 100 the second aliquot was directly analysed for metaproteome profiling (Fig. 1a ). Fig. S1 ). Among the 117 Kac peptides identified in 120 metaproteomic aliquot, only 6 were also identified in lysine acetylomic aliquot. To 121 evaluate the overlap of identified Kac proteins with proteins identified in unenriched 122 samples, we performed combined database search with raw files from both lysine 123 acetylomic and metaproteomic aliquots. In total, this study identified 25,144 protein 124 groups with 20,030 (80%) having at least one Kac modification. Interestingly, there were 125 3814 protein groups (15%) that were only inferred from Kac modified peptides ( Fig. 1d) , 126
suggesting an efficient enrichment of low abundant Kac proteins/peptides using the 127 current enrichment approach. 128
Characterization of the host and microbial Kac motifs in the human gut 129 microbiome samples 130 For the characterization of Kac sites, we used the 31,821 Kac sites identified in lysine 131 acetylomic aliquot, of which 31,307 were from microbes and 497 were of human origin 132 ( Fig. 2a ). We first characterized the amino acid distribution surrounding the acetylated 133 lysine, for both human and microbial Kac sites ( Fig. 2a ). Both human and microbial Kac 134 sites showed high frequency of glutamic acid (E) at -1 and leucine (L) and +1 positions. 135
The microbiome protein Kac sites were frequently flanked by repeats of the small, 136 hydrophobic amino acid, alanine (A); this was less common for the human protein Kac 137 sites ( Fig. 2a ). We further analyzed and visualized Kac protein motifs using pLogo [22] in 138 a sequence window of 13 amino acids ( Fig. 2b and c) . For human Kac sites, significant 139 over-representation was only observed for tyrosine (Y) at position -4 and +1 ( Fig. 2b and 140
Supplementary Data 1). In contrast, 68 significantly over-represented events were 141 observed for microbiome protein Kac sites, with E at position -1 and phenylalanine (F) at 142 position +1 being the most significantly over-represented ( Fig. 2c and Supplementary 143 Data 1). Interestingly, small amino acid, alanine, was observed as significantly over-144
represented at all the 12 positions assessed and its occupancy frequency was >9% 145 (10.3 ± 0.7%; mean ± SD) for all positions (Supplementary Data 1). In contrast, the 146 median occupation frequency of all other significantly over-represented events was 5.8% 147 (5.8 ± 3.6%; mean ± SD). These observations further confirm the high frequency of 148 alanine near the Kac sites in microbiome proteins. 149
We then examined whether different bacteria showed different protein Kac motifs in 150 microbiome. Among the five bacterial phyla (Firmicutes, Bacteroidetes, Actibobacteria, 151
Proteobacteria and Fusobacteria) with >100 Kac sites identified in this data set, high 152 similarity between different phyla was observed (all showed high frequency of E at We then performed functional enrichment analysis for microbial Kac proteins with the 184 Clusters of Orthologous Groups (COG) database. Using unmodified microbial proteins identified in metaproteomic aliquot as background, the enrichment analysis revealed that 186 microbial Kac proteins were significantly enriched in energy production and conversion, 187 transport or metabolism of several molecules (including amino acid, nucleotide, lipid and 188 coenzyme), cell wall biogenesis, replication as well as secondary metabolites 189 metabolism ( Fig. 3b ). Taxon (phylum)-specific functional analysis further showed that 190
Kac proteins from Firmicutes contributed to the majority proteins in energy production 191 and conversion, and those from Bacteroidetes contributed to nearly half of the Kac 192 proteins in translation and carbohydrate transport/metabolism although their total 193 abundances were much lower than those from Firmicutes (Fig. 3c) . compared to control subjects. In addition to those PLS-DA-identified differentially 210 abundant proteins or Kac sites, the proteins and Kac sites that were detected in greater 211 than 80% of samples in the CD group and less than 20% of samples in the control group 212 were also considered as increased in CD compared to controls. Similarly, the proteins 213 and Kac sites that were detected in less than 20% of samples in CD group and greater 214 than 80% of samples in control group were considered as decreased in CD. Altogether, 215 the current study identified 82 Kac sites that were increased, and 106 Kac sites that 216 were decreased, in CD compared to control subjects (Supplementary Data 6).
Among the 82 Kac sites that were increased in CD compared to control subjects, 46 218 were from human proteins and 36 were from microbiome proteins. However, only 6 Kac 219 sites that were decreased in CD were from human proteins and the remaining 100 220 upregulated Kac sites were from microbiome proteins. Interestingly, 68 out of the 100 221 upregulated microbial Kac sites were derived from Firmicutes, and 21 out of the 36 222 down-regulated microbial Kac sites were derived from Bacteroidetes (mainly from the 223 genus Bacteroides) (Fig. 4c ). The majority of the 68 upregulated Firmicutes-derived Kac 224 sites were from known SCFA-producing bacteria, including Faecalibacterium (21 sites), 225
Ruminococcus (8 sites), Eubacterium (6 sites), Roseburia (6 sites) and Blautia (5 sites). 226
Taxon-specific functional analysis showed that the microbial Kac sites that showed 227 increased abundances in CD were mainly from translation-related proteins of 228
Bacteroides; and the down-regulated microbial Kac sites in CD were mainly from 229 proteins that are involved in translation and carbohydrate metabolism of known SCFA-230 producers as mentioned above (Fig. 4c ). For example, among the 21 protein Kac sites of 231
Faecalibacterium that were decreased in CD, 6 sites were from proteins related to 232 carbohydrate metabolism, 4 from proteins related to energy metabolism, and 5 from 233 proteins related to translation. 234
We also performed comparative taxonomic analysis using the quantified Kac microbial 235 peptides and linear discriminant analysis effect size (LEfSe) analysis. The results 236 showed that the acetylome-based abundances of species Roseburia inulinivorans, 237
Eubacterium eligens and Megamonas funiformis were significantly decreased in CD 238 compared to that of controls, and the abundance of Bacilli was significantly increased 239 although its metaproteome-based abundance was decreased in CD ( Supplementary Fig.  240 S3 and Supplementary Note 1). The calculation of F/B ratios in both lysine acetylome 241 and metaproteome showed that lysine acetylome displayed higher F/B ratios than 242 metaproteome in both control (P = 0.03) and CD groups (P = 0.007) ( Fig. 4d ), which was 243 in agreement with the above observations in adult fecal microbiomes in this study. 244
Altered abundances of Kac sites on human proteins that are associated 245 with intestinal microbiomes in pediatric CD
246
As mentioned above, we identified 46 human protein Kac sites that showed increased 247 abundances and six human protein Kac sites that showed decreased abundances in CD 248 compared to control (Fig. 5 ). The six decreased human protein Kac sites in CD were on 249 chymotrypsin-like elastase family member 3A (CEL3A; 2 sites), CEL3B (2 sites), 250 ubiquitous mitochondrial creatine kinase (KCRU) and Xaa-Pro aminopeptidase 2 (XPP2). 251
The increased human protein Kac sites were mainly from the proteins lactotransferrin 252 (LTF; 10 sites) and calprotectin (protein S100A8 and S100A9; 7 sites). In addition, there To study the relative abundances of Kac sites to their total proteins, we calculated the 259 ratios between each of the 52 differentially abundant Kac sites and their corresponding 260 protein abundances in the metaproteomic aliquot ( Fig. 5 ). Twenty-seven out of the 52 261 sites exhibited significantly different site-to-protein ratios (Mann-Whitney test, P < 0.05) 262 or frequencies of detection between CD and control subjects. In total, the 52 differentially 263 abundant human protein Kac sites mapped to 26 proteins. Of these, six proteins (CEL3B, 264 KCRU, persulfide dioxygenase, IGLL5, IGA2 and G protein subunit beta 1) were not 265 significantly different at the protein abundance level between CD and control subjects, 266 and one protein (hemoglobin subunit alpha; HBA1) was not detected in the 267 metaproteomic analysis. 268
In the current study, we found that the total protein levels of both S100A8 and S100A9, 269 two monomers of a known CD biomarker calprotectin [24, 25], were significantly 270 increased in CD compared to controls ( Supplementary Fig. S4 ). In addition, we identified 271 5 Kac sites for protein S100A8 and 7 Kac sites for protein S100A9 in the lysine 272 acetylome data set, among which 2 for S100A8 and 5 for S100A9 were detected in <20% 273 of control samples and >80% of CD samples ( Fig. 6a-b) . Among all the identified 274 calprotectin Kac sites, only one site for S100A8 (K18) and one site for S100A9 (K38) 275 were quantified in ≥ 3 control samples, and both showed significantly lower abundances 276 in control than CD ( Fig. 6a-b) . Although there is no significant difference on the site-to-277 protein ratios of individual Kac site between CD and control samples ( Supplementary Fig.  278 S5), the ratios between the sum intensities of all Kac sites on S100A8, S100A9 and their 279 corresponding proteins were significantly higher in CD compared to control samples 280 (S100A8, P = 0.02; S100A9, P = 0.02; S100A8/9, P = 0.01) (Fig. 6c) . 281
Discussion

283
In the current study, we successfully utilized a recently developed anti-Kac motif 284 antibody mixture [19] for the enrichment of both human and microbial Kac peptides from 285 human gut microbiome samples. We demonstrated that the microbial Kac proteins were 286 significantly enriched in pathways such as energy production and lipid metabolism, 287
which is in line with the consensus that protein lysine acetylation plays ubiquitous roles 288 in both translation and metabolism [8, 9] . We also identified Kac motifs in microbiome 289 proteins that were distinct from that of human proteins. We examined both the host and Kac sites in the microbiome has not yet been studied. This is mainly due to the 301 extremely high complexity of microbiome samples, which requires an enrichment 302 approach with better coverage, and due to the bioinformatic challenges in efficiently 303 identifying and quantifying the microbiome Kac peptides. In the current study, we utilized 304 the seven anti-Kac monoclonal antibody cocktail, which was developed by Svinkina et al. 305 [19], for the enrichment of Kac peptides from tryptic digest of microbiome proteins. In 306 addition, we developed an integrated metaproteomics/lysine acetylomics data 307 processing workflow based on our previously developed MetaPro-IQ approach [20] and 308 . Therefore, the potential regulating effects of these microbial metabolites 334 (i.e., butyrate and acetate) may lead to higher global protein acetylation levels in SCFA-335 producers than others. Although further mechanistic studies are still required, our 336 findings suggest that lysine acetylation might be a potential target for manipulating the 337 growth and functional activity of SCFA-producers for the treatment of diseases. MLI aspirate samples were collected as previously described [3, 35] . Briefly, any existing 390 fluid and debris were first aspirated and discarded during colonoscopy. Sterile water was 391 then flushed onto the mucosal surface to dislodge the mucus layer from the epithelial 392 cells; the resulting fluid was then aspirated into a container. The latter was immediately 393 put on ice and transferred to the laboratory for further processing. 394
Sample processing, protein extraction and tryptic digestion 395
The fresh stool sample was immediately put on ice and subjected to differential 396 centrifugation and wash according to the procedures described previously [47] . The 397 resulting microbial pellets were then subjected to protein extraction using lysis buffer 398 containing 4% (w/v) SDS, 50 mM Tris-HCl (pH 8.0) and protease inhibitor (cOmplete TM , 399 mini protease inhibitor cocktail; Roche Diagnostics GmbH). Protein lysates were then 400 precipitated by adding five times the volume of lysis buffer of ice-cold acidified 401 acetone/ethanol buffer overnight at -20 °C. Precipitated proteins were then collected with 402 centrifugation at 16,000 g for 25 min at 4 °C, and washed three times by ice-cold 403 acetone before re-suspending in 6 M urea, 100 mM ammonium bicarbonate buffer [3] . for 40 min at room temperature; then the samples were diluted by ten folds with 100 mM 409 ammonium bicarbonate buffer followed by digestion using lysyl endopeptidase (Lys-C; 410
Wako Pure Chemical Corp., Osaka, Japan) for 4 hours and trypsin (Worthington 411 Biochemical Corp., Lakewood, NJ, USA) for overnight at room temperature. The 412 resulting digests were then subjected to desalting using C18 column as described 413 previously [47] . A small portion of the proteolytic peptides from each sample was used 414 for metaproteomic analysis (directly load for MS analysis), and the remainder was used 415
for Kac peptide enrichment. 416
For MLI aspirate samples, upon arriving at the laboratory, the samples were immediately 417 mixed with protease inhibitor (cOmplete TM , mini protease inhibitor cocktail; Roche 418
Diagnostics GmbH). The aspirate samples were first centrifuged at 700 g for 5 min at 419 4 °C and the supernatant collected for another centrifugation at 14,000 g for 20 min at 420 4 °C. The pellet fraction was harvested for protein extraction using lysis buffer consisting 421 of 4% (w/v) SDS, 8M urea, 50 mM Tris-HCl (pH 8.0) and cOmplete TM mini protease 422 inhibitor cocktail. Protein lysates were then precipitated and washed using ice-cold 423 acetone as described above. An equal amount (2.5 mg) of proteins for each sample was 424 then used for in-solution trypsin digestion and desalting as described previously [47] . A 425 small portion of the tryptic peptides (equivalent to 40 µg proteins) from each sample was 426 used for metaproteomic analysis (directly load for MS analysis), and the remainder was were first re-suspended in PTMScan® IAP Buffer and centrifuged at 10,000 g for 5 min 432 at 4 °C to remove any insoluble pellets. The supernatant was then added directly to the 433 tube containing Kac motif antibody beads and mixed immediately by slowly pipetting up 434 and down. The mixture was then incubated at 4 °C for 2 hr on a rotator. After incubation, 435 the beads were collected by centrifugation at 2,000 g for 30 s. The beads were then 436 washed twice with cold IAP buffer and three times with H 2 O. The peptides were eluted 437 by adding 55 µl of 0.15% (v/v) trifluoroacetic acid (TFA) to the beads and incubating for 438 10 min while mixing gently. The supernatant was collected through centrifuging at 2,000 439 g for 30 s and the remaining beads were mixed with another 50 µl of 0.15% (v/v) TFA for 440 another round of elution. Both eluents were then combined for desalting using C18 as detailed in Figure 1B . In this study, we used the reference protein database that was 469 generated in our previous metaproteomic studies of pediatric MLI aspirate samples [3] , 470 which we termed the IGC+ database in the current study. Briefly, the IGC+ database 471 value >2.0 were considered to be significantly different between control and CD groups. 524
Statistical significance of the difference between groups was evaluated using Mann-525
Whitney U test, unless otherwise indicated. The heatmap was generated using iMetaLab 526 (http://imetalab.ca/). The Sankey plot was generated using SankeyMATIC 527 (http://sankeymatic.com/). 528
Availability of data and materials 529
All MS proteomics data that support the findings of this study have been deposited to the 530 
